Report cover image

Global Antibody And Recombinant Protein Cdmo Market Research Report 2025(Status and Outlook)

Publisher Bosson Research
Published Aug 01, 2025
Length 185 Pages
SKU # BOSS20301902

Description

Report Overview

The global Antibody And Recombinant Protein Cdmo market size was estimated at USD 59130.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.00% during the forecast period.

This report provides a deep insight into the global Antibody And Recombinant Protein Cdmo market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antibody And Recombinant Protein Cdmo Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antibody And Recombinant Protein Cdmo market in any manner.

Global Antibody And Recombinant Protein Cdmo Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Batavia Biosciences

Grifols

Cerbios-Pharma SA

HALIX

Biovian Oy

Catalent

Goodwin Biotechnology

Merck

Hangzhou Hs-biopharm

Wuxibiologics

Bioinnobio

Thousand Oaks Biopharmaceuticals

Eurogentec

HJB

Bibo Pharma

MabPlex International

Genscriptprobio

Vetter

Etinpro (Beijing) Co

Boehringer Ingelheim BioXcellence

Lonza

3SBio Inc

Porton

Market Segmentation (by Type)

Antibody CDMO

Recombinant Protein CDMO

Market Segmentation (by Application)

Pharmaceutical Company

Biotechnology Company

Generic Company

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Antibody And Recombinant Protein Cdmo Market

Overview of the regional outlook of the Antibody And Recombinant Protein Cdmo Market:

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antibody And Recombinant Protein Cdmo Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Antibody And Recombinant Protein Cdmo, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Table of Contents

185 Pages
1 Research Methodology And Statistical Scope
1.1 Market Definition And Statistical Scope Of Antibody And Recombinant Protein Cdmo
1.2 Key Market Segments
1.2.1 Antibody And Recombinant Protein Cdmo Segment By Type
1.2.2 Antibody And Recombinant Protein Cdmo Segment By Application
1.3 Methodology & Sources Of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown And Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Antibody And Recombinant Protein Cdmo Market Overview
2.1 Global Market Overview
2.1.1 Global Antibody And Recombinant Protein Cdmo Market Size (M Usd) Estimates And Forecasts (2020-2033)
2.1.2 Global Antibody And Recombinant Protein Cdmo Sales Estimates And Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size By Region
3 Antibody And Recombinant Protein Cdmo Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Antibody And Recombinant Protein Cdmo Product Life Cycle
3.3 Global Antibody And Recombinant Protein Cdmo Sales By Manufacturers (2020-2025)
3.4 Global Antibody And Recombinant Protein Cdmo Revenue Market Share By Manufacturers (2020-2025)
3.5 Antibody And Recombinant Protein Cdmo Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
3.6 Global Antibody And Recombinant Protein Cdmo Average Price By Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, And Product Types
3.8 Antibody And Recombinant Protein Cdmo Market Competitive Situation And Trends
3.8.1 Antibody And Recombinant Protein Cdmo Market Concentration Rate
3.8.2 Global 5 And 10 Largest Antibody And Recombinant Protein Cdmo Players Market Share By Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Antibody And Recombinant Protein Cdmo Industry Chain Analysis
4.1 Antibody And Recombinant Protein Cdmo Industry Chain Analysis
4.2 Market Overview Of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development And Dynamics Of Antibody And Recombinant Protein Cdmo Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 Pest Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Antibody And Recombinant Protein Cdmo Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions And Their Impacts To Antibody And Recombinant Protein Cdmo Market
5.7 Esg Ratings Of Leading Companies
6 Antibody And Recombinant Protein Cdmo Market Segmentation By Type
6.1 Evaluation Matrix Of Segment Market Development Potential (Type)
6.2 Global Antibody And Recombinant Protein Cdmo Sales Market Share By Type (2020-2025)
6.3 Global Antibody And Recombinant Protein Cdmo Market Size Market Share By Type (2020-2025)
6.4 Global Antibody And Recombinant Protein Cdmo Price By Type (2020-2025)
7 Antibody And Recombinant Protein Cdmo Market Segmentation By Application
7.1 Evaluation Matrix Of Segment Market Development Potential (Application)
7.2 Global Antibody And Recombinant Protein Cdmo Market Sales By Application (2020-2025)
7.3 Global Antibody And Recombinant Protein Cdmo Market Size (M Usd) By Application (2020-2025)
7.4 Global Antibody And Recombinant Protein Cdmo Sales Growth Rate By Application (2020-2025)
8 Antibody And Recombinant Protein Cdmo Market Sales By Region
8.1 Global Antibody And Recombinant Protein Cdmo Sales By Region
8.1.1 Global Antibody And Recombinant Protein Cdmo Sales By Region
8.1.2 Global Antibody And Recombinant Protein Cdmo Sales Market Share By Region
8.2 Global Antibody And Recombinant Protein Cdmo Market Size By Region
8.2.1 Global Antibody And Recombinant Protein Cdmo Market Size By Region
8.2.2 Global Antibody And Recombinant Protein Cdmo Market Size Market Share By Region
8.3 North America
8.3.1 North America Antibody And Recombinant Protein Cdmo Sales By Country
8.3.2 North America Antibody And Recombinant Protein Cdmo Market Size By Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Antibody And Recombinant Protein Cdmo Sales By Country
8.4.2 Europe Antibody And Recombinant Protein Cdmo Market Size By Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Antibody And Recombinant Protein Cdmo Sales By Region
8.5.2 Asia Pacific Antibody And Recombinant Protein Cdmo Market Size By Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Antibody And Recombinant Protein Cdmo Sales By Country
8.6.2 South America Antibody And Recombinant Protein Cdmo Market Size By Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East And Africa
8.7.1 Middle East And Africa Antibody And Recombinant Protein Cdmo Sales By Region
8.7.2 Middle East And Africa Antibody And Recombinant Protein Cdmo Market Size By Region
8.7.3 Saudi Arabia Market Overview
8.7.4 Uae Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Antibody And Recombinant Protein Cdmo Market Production By Region
9.1 Global Production Of Antibody And Recombinant Protein Cdmo By Region(2020-2025)
9.2 Global Antibody And Recombinant Protein Cdmo Revenue Market Share By Region (2020-2025)
9.3 Global Antibody And Recombinant Protein Cdmo Production, Revenue, Price And Gross Margin (2020-2025)
9.4 North America Antibody And Recombinant Protein Cdmo Production
9.4.1 North America Antibody And Recombinant Protein Cdmo Production Growth Rate (2020-2025)
9.4.2 North America Antibody And Recombinant Protein Cdmo Production, Revenue, Price And Gross Margin (2020-2025)
9.5 Europe Antibody And Recombinant Protein Cdmo Production
9.5.1 Europe Antibody And Recombinant Protein Cdmo Production Growth Rate (2020-2025)
9.5.2 Europe Antibody And Recombinant Protein Cdmo Production, Revenue, Price And Gross Margin (2020-2025)
9.6 Japan Antibody And Recombinant Protein Cdmo Production (2020-2025)
9.6.1 Japan Antibody And Recombinant Protein Cdmo Production Growth Rate (2020-2025)
9.6.2 Japan Antibody And Recombinant Protein Cdmo Production, Revenue, Price And Gross Margin (2020-2025)
9.7 China Antibody And Recombinant Protein Cdmo Production (2020-2025)
9.7.1 China Antibody And Recombinant Protein Cdmo Production Growth Rate (2020-2025)
9.7.2 China Antibody And Recombinant Protein Cdmo Production, Revenue, Price And Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Batavia Biosciences
10.1.1 Batavia Biosciences Basic Information
10.1.2 Batavia Biosciences Antibody And Recombinant Protein Cdmo Product Overview
10.1.3 Batavia Biosciences Antibody And Recombinant Protein Cdmo Product Market Performance
10.1.4 Batavia Biosciences Business Overview
10.1.5 Batavia Biosciences Swot Analysis
10.1.6 Batavia Biosciences Recent Developments
10.2 Grifols
10.2.1 Grifols Basic Information
10.2.2 Grifols Antibody And Recombinant Protein Cdmo Product Overview
10.2.3 Grifols Antibody And Recombinant Protein Cdmo Product Market Performance
10.2.4 Grifols Business Overview
10.2.5 Grifols Swot Analysis
10.2.6 Grifols Recent Developments
10.3 Cerbios-pharma Sa
10.3.1 Cerbios-pharma Sa Basic Information
10.3.2 Cerbios-pharma Sa Antibody And Recombinant Protein Cdmo Product Overview
10.3.3 Cerbios-pharma Sa Antibody And Recombinant Protein Cdmo Product Market Performance
10.3.4 Cerbios-pharma Sa Business Overview
10.3.5 Cerbios-pharma Sa Swot Analysis
10.3.6 Cerbios-pharma Sa Recent Developments
10.4 Halix
10.4.1 Halix Basic Information
10.4.2 Halix Antibody And Recombinant Protein Cdmo Product Overview
10.4.3 Halix Antibody And Recombinant Protein Cdmo Product Market Performance
10.4.4 Halix Business Overview
10.4.5 Halix Recent Developments
10.5 Biovian Oy
10.5.1 Biovian Oy Basic Information
10.5.2 Biovian Oy Antibody And Recombinant Protein Cdmo Product Overview
10.5.3 Biovian Oy Antibody And Recombinant Protein Cdmo Product Market Performance
10.5.4 Biovian Oy Business Overview
10.5.5 Biovian Oy Recent Developments
10.6 Catalent
10.6.1 Catalent Basic Information
10.6.2 Catalent Antibody And Recombinant Protein Cdmo Product Overview
10.6.3 Catalent Antibody And Recombinant Protein Cdmo Product Market Performance
10.6.4 Catalent Business Overview
10.6.5 Catalent Recent Developments
10.7 Goodwin Biotechnology
10.7.1 Goodwin Biotechnology Basic Information
10.7.2 Goodwin Biotechnology Antibody And Recombinant Protein Cdmo Product Overview
10.7.3 Goodwin Biotechnology Antibody And Recombinant Protein Cdmo Product Market Performance
10.7.4 Goodwin Biotechnology Business Overview
10.7.5 Goodwin Biotechnology Recent Developments
10.8 Merck
10.8.1 Merck Basic Information
10.8.2 Merck Antibody And Recombinant Protein Cdmo Product Overview
10.8.3 Merck Antibody And Recombinant Protein Cdmo Product Market Performance
10.8.4 Merck Business Overview
10.8.5 Merck Recent Developments
10.9 Hangzhou Hs-biopharm
10.9.1 Hangzhou Hs-biopharm Basic Information
10.9.2 Hangzhou Hs-biopharm Antibody And Recombinant Protein Cdmo Product Overview
10.9.3 Hangzhou Hs-biopharm Antibody And Recombinant Protein Cdmo Product Market Performance
10.9.4 Hangzhou Hs-biopharm Business Overview
10.9.5 Hangzhou Hs-biopharm Recent Developments
10.10 Wuxibiologics
10.10.1 Wuxibiologics Basic Information
10.10.2 Wuxibiologics Antibody And Recombinant Protein Cdmo Product Overview
10.10.3 Wuxibiologics Antibody And Recombinant Protein Cdmo Product Market Performance
10.10.4 Wuxibiologics Business Overview
10.10.5 Wuxibiologics Recent Developments
10.11 Bioinnobio
10.11.1 Bioinnobio Basic Information
10.11.2 Bioinnobio Antibody And Recombinant Protein Cdmo Product Overview
10.11.3 Bioinnobio Antibody And Recombinant Protein Cdmo Product Market Performance
10.11.4 Bioinnobio Business Overview
10.11.5 Bioinnobio Recent Developments
10.12 Thousand Oaks Biopharmaceuticals
10.12.1 Thousand Oaks Biopharmaceuticals Basic Information
10.12.2 Thousand Oaks Biopharmaceuticals Antibody And Recombinant Protein Cdmo Product Overview
10.12.3 Thousand Oaks Biopharmaceuticals Antibody And Recombinant Protein Cdmo Product Market Performance
10.12.4 Thousand Oaks Biopharmaceuticals Business Overview
10.12.5 Thousand Oaks Biopharmaceuticals Recent Developments
10.13 Eurogentec
10.13.1 Eurogentec Basic Information
10.13.2 Eurogentec Antibody And Recombinant Protein Cdmo Product Overview
10.13.3 Eurogentec Antibody And Recombinant Protein Cdmo Product Market Performance
10.13.4 Eurogentec Business Overview
10.13.5 Eurogentec Recent Developments
10.14 Hjb
10.14.1 Hjb Basic Information
10.14.2 Hjb Antibody And Recombinant Protein Cdmo Product Overview
10.14.3 Hjb Antibody And Recombinant Protein Cdmo Product Market Performance
10.14.4 Hjb Business Overview
10.14.5 Hjb Recent Developments
10.15 Bibo Pharma
10.15.1 Bibo Pharma Basic Information
10.15.2 Bibo Pharma Antibody And Recombinant Protein Cdmo Product Overview
10.15.3 Bibo Pharma Antibody And Recombinant Protein Cdmo Product Market Performance
10.15.4 Bibo Pharma Business Overview
10.15.5 Bibo Pharma Recent Developments
10.16 Mabplex International
10.16.1 Mabplex International Basic Information
10.16.2 Mabplex International Antibody And Recombinant Protein Cdmo Product Overview
10.16.3 Mabplex International Antibody And Recombinant Protein Cdmo Product Market Performance
10.16.4 Mabplex International Business Overview
10.16.5 Mabplex International Recent Developments
10.17 Genscriptprobio
10.17.1 Genscriptprobio Basic Information
10.17.2 Genscriptprobio Antibody And Recombinant Protein Cdmo Product Overview
10.17.3 Genscriptprobio Antibody And Recombinant Protein Cdmo Product Market Performance
10.17.4 Genscriptprobio Business Overview
10.17.5 Genscriptprobio Recent Developments
10.18 Vetter
10.18.1 Vetter Basic Information
10.18.2 Vetter Antibody And Recombinant Protein Cdmo Product Overview
10.18.3 Vetter Antibody And Recombinant Protein Cdmo Product Market Performance
10.18.4 Vetter Business Overview
10.18.5 Vetter Recent Developments
10.19 Etinpro (Beijing) Co
10.19.1 Etinpro (Beijing) Co Basic Information
10.19.2 Etinpro (Beijing) Co Antibody And Recombinant Protein Cdmo Product Overview
10.19.3 Etinpro (Beijing) Co Antibody And Recombinant Protein Cdmo Product Market Performance
10.19.4 Etinpro (Beijing) Co Business Overview
10.19.5 Etinpro (Beijing) Co Recent Developments
10.20 Boehringer Ingelheim Bioxcellence
10.20.1 Boehringer Ingelheim Bioxcellence Basic Information
10.20.2 Boehringer Ingelheim Bioxcellence Antibody And Recombinant Protein Cdmo Product Overview
10.20.3 Boehringer Ingelheim Bioxcellence Antibody And Recombinant Protein Cdmo Product Market Performance
10.20.4 Boehringer Ingelheim Bioxcellence Business Overview
10.20.5 Boehringer Ingelheim Bioxcellence Recent Developments
10.21 Lonza
10.21.1 Lonza Basic Information
10.21.2 Lonza Antibody And Recombinant Protein Cdmo Product Overview
10.21.3 Lonza Antibody And Recombinant Protein Cdmo Product Market Performance
10.21.4 Lonza Business Overview
10.21.5 Lonza Recent Developments
10.22 3sbio Inc
10.22.1 3sbio Inc Basic Information
10.22.2 3sbio Inc Antibody And Recombinant Protein Cdmo Product Overview
10.22.3 3sbio Inc Antibody And Recombinant Protein Cdmo Product Market Performance
10.22.4 3sbio Inc Business Overview
10.22.5 3sbio Inc Recent Developments
10.23 Porton
10.23.1 Porton Basic Information
10.23.2 Porton Antibody And Recombinant Protein Cdmo Product Overview
10.23.3 Porton Antibody And Recombinant Protein Cdmo Product Market Performance
10.23.4 Porton Business Overview
10.23.5 Porton Recent Developments
11 Antibody And Recombinant Protein Cdmo Market Forecast By Region
11.1 Global Antibody And Recombinant Protein Cdmo Market Size Forecast
11.2 Global Antibody And Recombinant Protein Cdmo Market Forecast By Region
11.2.1 North America Market Size Forecast By Country
11.2.2 Europe Antibody And Recombinant Protein Cdmo Market Size Forecast By Country
11.2.3 Asia Pacific Antibody And Recombinant Protein Cdmo Market Size Forecast By Region
11.2.4 South America Antibody And Recombinant Protein Cdmo Market Size Forecast By Country
11.2.5 Middle East And Africa Forecasted Sales Of Antibody And Recombinant Protein Cdmo By Country
12 Forecast Market By Type And By Application (2026-2033)
12.1 Global Antibody And Recombinant Protein Cdmo Market Forecast By Type (2026-2033)
12.1.1 Global Forecasted Sales Of Antibody And Recombinant Protein Cdmo By Type (2026-2033)
12.1.2 Global Antibody And Recombinant Protein Cdmo Market Size Forecast By Type (2026-2033)
12.1.3 Global Forecasted Price Of Antibody And Recombinant Protein Cdmo By Type (2026-2033)
12.2 Global Antibody And Recombinant Protein Cdmo Market Forecast By Application (2026-2033)
12.2.1 Global Antibody And Recombinant Protein Cdmo Sales (K Units) Forecast By Application
12.2.2 Global Antibody And Recombinant Protein Cdmo Market Size (M Usd) Forecast By Application (2026-2033)
13 Conclusion And Key Findings
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.